{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:33:40Z","timestamp":1784086420763,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.thromres.2023.10.002","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:23:51Z","timestamp":1696832631000},"page":"84-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cancer-associated splanchnic vein thrombosis: Clinical features upon diagnosis and short-term outcomes"],"prefix":"10.1016","volume":"231","author":[{"given":"Adri\u00e1n","family":"Garc\u00eda-Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Criado-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Carnevali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Aramberri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"D\u00edaz-Pedroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"05","key":"10.1016\/j.thromres.2023.10.002_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0035-1550439","article-title":"Splanchnic vein thrombosis","volume":"41","author":"Valla","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2023.10.002_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.thromres.2012.08.259","article-title":"Clinical approach to splanchnic vein thrombosis: risk factors and treatment","volume":"130","author":"Riva","year":"2012","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.002_bb0015","first-page":"200","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.002_bb0020","first-page":"99","article-title":"Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry","volume":"40","author":"Ageno","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.10.002_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2021.03.018","article-title":"Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes","volume":"202","author":"Kawata","year":"2021","journal-title":"Thromb. Res."},{"issue":"15","key":"10.1016\/j.thromres.2023.10.002_bb0030","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1182\/bloodadvances.2022007961","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis","volume":"6","author":"Candeloro","year":"2022","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.002_bb0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2023.10.002_bb0040","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term Clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"13","key":"10.1016\/j.thromres.2023.10.002_bb0045","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies","volume":"12","author":"Ogren","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.002_bb0050","first-page":"371","article-title":"Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer","volume":"106","author":"Menapace","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.10.002_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-0035-1550429","article-title":"Risk factors, diagnosis, management, and outcome of splanchnic vein thrombosis: a retrospective analysis","volume":"41","author":"Derman","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.10.002_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.thromres.2017.06.030","article-title":"Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses","volume":"163","author":"Riva","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.10.002_bb0065","series-title":"9th International Conference on Thrombosis and Hemostasis Issues in Cancer","article-title":"Cancer-associated splanchnic venous thrombosis: clinical findings at presentation","author":"Garc\u00eda-Villa","year":"2018"},{"issue":"8","key":"10.1016\/j.thromres.2023.10.002_bb0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1055\/s-0040-1722607","article-title":"Cancer-associated splanchnic vein thrombosis","volume":"47","author":"Cohen","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.10.002_bb0075","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/j.thromres.2010.02.010","article-title":"Incidental venous thromboembolism in cancer patients: prevalence and consequence","volume":"125","author":"Douma","year":"2010","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.002_bb0080","first-page":"7","article-title":"Cancer statistics, 2018: Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.thromres.2023.10.002_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2018.02.143","article-title":"Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis","volume":"164","author":"Tufano","year":"2018","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.002_bb0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11239-015-1171-0","article-title":"Managing unusual presentations of venous thromboembolism","volume":"39","author":"Ageno","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2023.10.002_bb0095","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(15)50432-5","article-title":"The mechanisms of cancer-associated thrombosis","volume":"135","author":"Falanga","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.10.002_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2019.11.023","article-title":"Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer","volume":"185","author":"Afzal","year":"2020","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.thromres.2023.10.002_bb0105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2015-03-631119","article-title":"Splanchnic venous thrombosis is a marker of cancer and a prognostic factor for cancer survival","volume":"126","author":"S\u00f8gaard","year":"2015","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.thromres.2023.10.002_bb0110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO Clinical Practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2023.10.002_bb0115","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest."},{"issue":"6","key":"10.1016\/j.thromres.2023.10.002_bb0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"issue":"11","key":"10.1016\/j.thromres.2023.10.002_bb0125","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.002_bb0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatol Baltim Md."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.002_bb0135","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12121","article-title":"Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding","volume":"11","author":"Spaander","year":"2013","journal-title":"J Thromb Haemost JTH."},{"issue":"25","key":"10.1016\/j.thromres.2023.10.002_bb0140","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood-2014-07-551515","article-title":"How I treat splanchnic vein thrombosis","volume":"124","author":"Ageno","year":"2014","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.002_bb0145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/asheducation-2014.1.318","article-title":"Management of incidental splanchnic vein thrombosis in cancer patients","volume":"2014","author":"Kreuziger","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Program."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.002_bb0150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jth.15214","article-title":"Clinical history of cancer-associated splanchnic vein thrombosis","volume":"19","author":"Valeriani","year":"2021","journal-title":"J Thromb Haemost JTH."},{"issue":"8","key":"10.1016\/j.thromres.2023.10.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-term outcome of splanchnic vein thrombosis in cirrhosis","volume":"9","author":"Senzolo","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.002_bb0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology."},{"issue":"9","key":"10.1016\/j.thromres.2023.10.002_bb0165","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2021","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.thromres.2023.10.002_bb0170","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC subcommittee control of anticoagulation","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J Thromb Haemost JTH."},{"issue":"14","key":"10.1016\/j.thromres.2023.10.002_bb0175","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2013-04-460162","article-title":"Treatment of cancer-associated thrombosis","volume":"122","author":"Lee","year":"2013","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.002_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Vascular diseases of the liver","volume":"64","author":"Clinical Practice Guidelines","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.002_bb0185","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatol Baltim Md."},{"issue":"6","key":"10.1016\/j.thromres.2023.10.002_bb0190","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","article-title":"Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest."},{"issue":"6","key":"10.1016\/j.thromres.2023.10.002_bb0195","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2352-3026(16)30020-5","article-title":"Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry","volume":"3","author":"Riva","year":"2016","journal-title":"Lancet Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.002_bb0200","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:39Z","timestamp":1758736299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823002797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"alternative-id":["S0049384823002797"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated splanchnic vein thrombosis: Clinical features upon diagnosis and short-term outcomes","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}